(MedPage Today) — MADRID — For uncontrolled or treatment-resistant hypertension, adding the novel aldosterone synthase inhibitor baxdrostat improved blood pressure in the randomized BaxHTN trial.
Seated systolic blood pressure improved by…
Source link : https://www.medpagetoday.com/meetingcoverage/esc/117241
Author :
Publish date : 2025-08-30 14:15:00
Copyright for syndicated content belongs to the linked Source.
